aDepartment of Orthopaedic Surgery, University of Minnesota, Minneapolis, MN;

bDepartment of Orthopaedic Surgery, Hennepin County Medical Center, Minneapolis, MN;

cDepartment of Orthopaedic Surgery, TRIA Orthopaedic Center, Bloomington, MN;

dDepartment of Orthopaedic Surgery, Methodist Hospital, St. Louis Park, MN;

eDepartment of Orthopaedic Surgery, Vanderbilt University Medical Center, Nashville, TN; and

fDepartment of Orthopaedic Surgery, Boston University Medical Center, Boston, MA.

Reprints: Brian P. Cunningham, MD, Department of Orthopaedic Surgery, Park Nicollet Methodist Hospital, 6500 Excelsior Boulevard, St. Louis Park, MN 55426 (e-mail: [email protected]).

B. P. Cunningham reports a grant from Integra associated with the conduct of the study. B. P. Cunningham's spouse is the CEO and founder of CODE Technology. A. Schmidt reports stock or stock options in ActivOrtho, Conventus Orthopaedics, Enova Illumination, Epien, and Epix VAN. A. Schmidt is also on the editorial or governing board for OTA International. W. T. Obremskey is on the editorial or governing board for JOT, JBJS, and JAAOS, and is a committee or board member for Southeastern Fracture Consortium. P. Tornetta is on the editorial or governing board for JOT, and reports IP royalties from Smith & Nephew. P. Tornetta reports publishing royalties, financial or material support from Wolters Kluwer Health. For the remaining authors, none were declared.